Linelle Diario

Ethinylestradiol and Levonorgestrel, the active ingredients in Linelle Diario, are a combined oral contraceptive presented as an oral tablet for oral use. It prevents pregnancy in women of reproductive age.

GNH USA supplies Linelle Diario as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Linelle Diario, a combined oral contraceptive, is used within the hormonal regulation pathway to prevent unintended pregnancy.

- Contraception: prevents pregnancy in women of childbearing potential. - Menstrual cycle regulation: helps achieve more predictable menstrual bleeding patterns. - Acne management: may reduce moderate acne associated with hormonal fluctuations.

Linelle Diario may be associated with a range of adverse reactions, which are generally categorized by frequency and severity.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Breast tenderness: temporary swelling or discomfort. - Headache: occasional tension‑type headache. - Breakthrough bleeding: spotting between periods. - Mood changes: mild irritability or mood swings. - Weight fluctuation: slight increase or decrease.

Serious or Rare Side Effects: - Venous thromboembolism: deep‑vein thrombosis or pulmonary embolism. - Arterial thrombosis: stroke or myocardial infarction. - Severe hypertension: sudden rise in blood pressure. - Liver tumor: benign hepatic adenoma. - Anaphylaxis: rare severe allergic reaction.

Before prescribing Linelle Diario, clinicians should consider several precautionary measures to ensure safe use.

- Cardiovascular risk assessment: evaluate history of thromboembolic disease or smoking. - Hepatic function review: contraindicated in severe liver impairment. - Smoking cessation: advise women over 35 to stop smoking. - Drug interaction check: identify concurrent enzyme‑inducing agents. - Pregnancy confirmation: ensure patient is not pregnant before initiation. - Store at ambient temperature: keep below 25°C, protect from moisture and light.

Linelle Diario can interact with other medicines, affecting its contraceptive efficacy or safety profile.

Major Interactions (Avoid): - Strong CYP3A4 inducers (e.g., rifampicin, carbamazepine, phenytoin): may markedly reduce hormone levels. - Antiretroviral protease inhibitors (e.g., ritonavir): can increase hormone concentrations and risk of side effects.

Moderate Interactions (Monitor Closely): - Antifungal agents (e.g., ketoconazole, itraconazole): may increase plasma hormone levels. - St. John’s Wort: may lower contraceptive effectiveness. - Certain antibiotics (e.g., tetracycline, metronidazole): minimal effect but monitor for breakthrough bleeding.